Oscar Health, Inc. (OSCR)
NYSE: OSCR · Real-Time Price · USD
13.42
-0.29 (-2.12%)
At close: Feb 13, 2026, 4:00 PM EST
13.55
+0.13 (0.94%)
After-hours: Feb 13, 2026, 7:59 PM EST

Oscar Health Statistics

Total Valuation

Oscar Health has a market cap or net worth of $3.99 billion. The enterprise value is $1.72 billion.

Market Cap3.99B
Enterprise Value 1.72B

Important Dates

The last earnings date was Tuesday, February 10, 2026, before market open.

Earnings Date Feb 10, 2026
Ex-Dividend Date n/a

Share Statistics

Oscar Health has 297.43 million shares outstanding. The number of shares has decreased by -1.30% in one year.

Current Share Class 261.84M
Shares Outstanding 297.43M
Shares Change (YoY) -1.30%
Shares Change (QoQ) +9.25%
Owned by Insiders (%) 2.95%
Owned by Institutions (%) 50.05%
Float 249.15M

Valuation Ratios

PE Ratio n/a
Forward PE 30.96
PS Ratio 0.30
Forward PS 0.31
PB Ratio 4.08
P/TBV Ratio 4.08
P/FCF Ratio 3.77
P/OCF Ratio 3.65
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 0.15
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF 1.62

Financial Position

The company has a current ratio of 0.95, with a Debt / Equity ratio of 0.51.

Current Ratio 0.95
Quick Ratio 0.92
Debt / Equity 0.51
Debt / EBITDA n/a
Debt / FCF 0.47
Interest Coverage -22.52

Financial Efficiency

Return on equity (ROE) is -44.35% and return on invested capital (ROIC) is -24.53%.

Return on Equity (ROE) -44.35%
Return on Assets (ROA) -4.44%
Return on Invested Capital (ROIC) -24.53%
Return on Capital Employed (ROCE) -27.10%
Weighted Average Cost of Capital (WACC) 13.36%
Revenue Per Employee $4.88M
Profits Per Employee -$184,646
Employee Count2,400
Asset Turnover 2.10
Inventory Turnover n/a

Taxes

In the past 12 months, Oscar Health has paid $5.61 million in taxes.

Income Tax 5.61M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -2.47% in the last 52 weeks. The beta is 1.90, so Oscar Health's price volatility has been higher than the market average.

Beta (5Y) 1.90
52-Week Price Change -2.47%
50-Day Moving Average 15.35
200-Day Moving Average 16.45
Relative Strength Index (RSI) 40.10
Average Volume (20 Days) 9,293,461

Short Selling Information

The latest short interest is 25.27 million, so 8.50% of the outstanding shares have been sold short.

Short Interest 25.27M
Short Previous Month 25.11M
Short % of Shares Out 8.50%
Short % of Float 10.14%
Short Ratio (days to cover) 3.08

Income Statement

In the last 12 months, Oscar Health had revenue of $11.70 billion and -$443.15 million in losses. Loss per share was -$1.69.

Revenue11.70B
Gross Profit 1.68B
Operating Income -396.36M
Pretax Income -437.30M
Net Income -443.15M
EBITDA -367.47M
EBIT -396.36M
Loss Per Share -$1.69
Full Income Statement

Balance Sheet

The company has $3.99 billion in cash and $498.80 million in debt, with a net cash position of $2.28 billion or $7.65 per share.

Cash & Cash Equivalents 3.99B
Total Debt 498.80M
Net Cash 2.28B
Net Cash Per Share $7.65
Equity (Book Value) 980.74M
Book Value Per Share 3.29
Working Capital -249.18M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $1.09 billion and capital expenditures -$36.37 million, giving a free cash flow of $1.06 billion.

Operating Cash Flow 1.09B
Capital Expenditures -36.37M
Free Cash Flow 1.06B
FCF Per Share $3.56
Full Cash Flow Statement

Margins

Gross margin is 14.38%, with operating and profit margins of -3.39% and -3.79%.

Gross Margin 14.38%
Operating Margin -3.39%
Pretax Margin -3.74%
Profit Margin -3.79%
EBITDA Margin -3.14%
EBIT Margin -3.39%
FCF Margin 9.05%

Dividends & Yields

Oscar Health does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 1.30%
Shareholder Yield 1.30%
Earnings Yield -11.10%
FCF Yield 26.52%

Analyst Forecast

The average price target for Oscar Health is $17.00, which is 26.68% higher than the current price. The consensus rating is "Hold".

Price Target $17.00
Price Target Difference 26.68%
Analyst Consensus Hold
Analyst Count 7
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 3